Prediction of Clinical Outcomes and Immunotherapy Response in Breast Cancer Based on T Cell-Mediated Tumor Killing-Related Traits
The index related to TTK appears to be a valuable biomarker for effectively assessing survival and forecasting the success of therapy in patients with BRCA. This risk metric can enable timely and targeted early interventions for patients, thus promoting advancements in personalized medicine and enhancing the research in precise immuno-oncology.
Authors
- Ming Cai
- Z. Jennifer Huang (ORCID: https://orcid.org/0009-0005-9868-1397)
- Ronghua Yuan (ORCID: https://orcid.org/0000-0001-6435-9555)
- Jie Chen (ORCID: https://orcid.org/0000-0003-3435-0351)
Institutions
- Nantong University (CN)
- Affiliated Hospital of Nantong University (CN)
- Second People's Hospital of NanTong (CN)
Publication Details
- Journal
- Endocrine Metabolic & Immune Disorders - Drug Targets
- Published
- 2025-12-04
- DOI
- https://doi.org/10.2174/0118715303429021251024053150
- Primary Topic
- Cancer Immunotherapy and Biomarkers
- Type
- article
- Field-Weighted Citation Impact
- 0.00